FDA Orders Kratom Recall for Salmonella Manufacturer refused to cooperate in voluntary process

Kratom is an increasingly popular herbal product, mostly imported from Southeast Asia, with opioid-like psychoactive properties. It is widely promoted for treating pain and symptoms of opioid withdrawal. The FDA said it had asked Triangle on March 30 to initiate a recall, which the firm ignored. The agency issued another notice to Triangle the following day, ordering the company to stop distributing its kratom products. When that notice also didn't elicit a response, the agency said, on Monday it followed through with a mandatory recall order. Other firms have complied with FDA requests to recall their kratom products, the agency said. https://www.medpagetoday.com/publichealthpolicy/publichealth/72126?xid=nl_mpt_DHE_2018-04-04&eun=g721819d0r&pos=4&utm_source=Sailthru&utm_medium=email&utm_campaign=Daily%20Headlines%202018-04-04&utm_term=Daily%20Headlines%20-%20Active%20User%20-%20180%20days